Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern

Garg R, Liu Q, Van Kessel J, et al. Vaccine. Published online May 14, 2024. doi:10.1016/j.vaccine.2024.05.028

VFI headquarters and Geneva laboratories

Rue du Champ-Blanchod 4
1228 Plan-les-Ouates
Switzerland

VFI Lausanne laboratories

Route de la Corniche 5
1066 Epalinges
Switzerland

contact@vformulation.org
VFI on LinkedIn

© 2025 Vaccine Formulation Institute